S18327

CAT: 0804-HY-165527Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-165527Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

S18327 is a multi-target antipsychotic agent. S18327 exerts its efficacy by acting on multiple neurotransmitter systems in the brain, and it has antagonistic effects on dopamine receptors (particularly the D2 receptor) and 5-hydroxytryptamine 2A receptors (5-HT2A receptor). S18327 can counteract excessive dopamine activity and hypo-function of glutamate. S18327 exhibits a multi-parameter pharmacological profile that is highly similar to that of Clozapine. S18327 can produce the same discriminative stimulus as Clozapine, improve cognitive filtering deficits associated with schizophrenia, and display anxiolytic properties. S18327 has relatively weak affinity for histaminergic receptors and muscarinic receptors, which avoids the side effects of Clozapine[1].

CAS Number

200398-40-9

UNSPSC

12352005

Target

5-HT Receptor; Dopamine Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Smiles

O=C1N(CCN1CCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)C5=CC=CC=C5

Molecular Formula

C23H25FN4O2

Molecular Weight

408.47

References & Citations

[1]Millan MJ, et al. S18327 (1-[2-[4- (6-fluoro-1, 2-benzisoxazol-3-yl) piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha (1) - and alpha (2) -adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. J Pharmacol Exp Ther. 2000 Jan;292 (1) :54-66.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

5-HT2 Receptor; D2 Receptor

Alternative Products

Catalog	Name
T202211-01	S18327

S18327

Alternative Products

Popular Products